IL12B and breast cancer: The IL12B gene a BC risk reduction was evident for the rs3212227G-rs2546892G-rs2569254C-rs3181216A-rs730691T genotypes when compared to the TGCAT genotype (OR 0.62, 95% CI: 0.42–0.91, P = 0.01) as seen in Table 4.